Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a

Authors :: Daniele Roberto, Giacobbe
Juergen, Prattes
Joost, Wauters
Silvia, Dettori
Alessio, Signori
Jon, Salmanton-García
Johan, Maertens
Marc, Bourgeois
Marijke, Reynders
Lynn, Rutsaert
Niels, Van Regenmortel
Piet, Lormans
Simon, Feys
Nikolay, Klimko
Olga, Shadrivova
Oliver A, Cornely
Riina, Rautemaa-Richardson
Philipp, Koehler
Katrien, Lagrou
Matteo, Bassetti
Martin, Hoenigl
Source :: Journal of clinical microbiology. 60(4)
Publication Year :: 2022
Abstract: Critically ill patients with coronavirus disease 2019 (COVID-19) may develop COVID-19-associated pulmonary aspergillosis (CAPA), which impacts their chances of survival. Whether positive bronchoalveolar lavage fluid (BALF) mycological tests can be used as a survival proxy remains unknown. We conducted a

Subjects :: Invasive Pulmonary Aspergillosis
Mannans
Intensive Care Units
Aspergillus
Critical Illness
COVID-19
Galactose
Humans
Mycology
Pulmonary Aspergillosis
Prognosis
Bronchoalveolar Lavage Fluid
Sensitivity and Specificity

Tools